Plasma active matrix metalloproteinase 9 associated to diastolic dysfunction in patients with coronary artery disease

被引：7
|
作者：
Chu, John W. [1 ]
Jones, Gregory T. [2 ]
Tarr, Gregory P. [2 ]
Phillips, L. Vicky [2 ]
Wilkins, Gerard T. [1 ]
van Rij, Andre M. [2 ]
Williams, Michael J. A. [1 ]
机构：
[1] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin 9001, New Zealand
[2] Univ Otago, Dunedin Sch Med, Dept Surg, Dunedin 9001, New Zealand
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 147卷 / 02期
关键词：
Diastolic function; Extracellular matrix; Matrix metalloproteinase; Coronary artery disease; DOPPLER-ECHOCARDIOGRAPHY; STANDARDS COMMITTEE; OF-ECHOCARDIOGRAPHY; RECOMMENDATIONS; QUANTIFICATION; GUIDELINES;
D O I：
10.1016/j.ijcard.2010.12.093
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：336 / 338
页数：4
相关论文
共 50 条
  • [1] Plasma leptin levels are associated with diastolic dysfunction in patients with coronary artery disease
    Puurunen, V. P.
    Lepojarvi, E. S.
    Piira, O. P.
    Junttila, M. J.
    Ukkola, O.
    Huikuri, H. V.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1184 - 1184
  • [2] Urine and plasma matrix metalloproteinase 9 and 2 levels in patients with coronary artery disease
    Fitzsimmons, P
    Lawrence, ME
    Forough, R
    Weylie, B
    Gantt, DS
    Dehmer, GJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 6A - 6A
  • [3] Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis
    Jones, Gregory T.
    Kay, I. Patrick
    Chu, J. W. S.
    Wilkins, G. T.
    Phillips, L. V.
    McCormick, M.
    van Rij, A. M.
    Williams, M. J. A.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) : E121 - E125
  • [4] Plasma active matrix metalloproteinase 9 and indices of diastolic function in patients with preserved systolic function
    Chu, John W.
    Jones, Gregory T.
    Tarr, Gregory P.
    Phillips, L. Vicky
    Wilkins, Gerard T.
    van Rij, Andre M.
    Williams, Michael J. A.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1242 - 1246
  • [5] Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease
    Fitzsimmons, Patrick J.
    Forough, Reza
    Lawrence, Mark E.
    Gantt, D. Scott
    Rajab, M. Hasan
    Kim, Hyunsun
    Weylie, Brian
    Spiekerman, A. Michael
    Dehmer, Gregory J.
    [J]. ATHEROSCLEROSIS, 2007, 194 (01) : 196 - 203
  • [6] Matrix metalloproteinase expression in patients with coronary artery disease
    Wu, TC
    Leu, HB
    Lin, CP
    Lin, WT
    Chen, JW
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 31 - 31
  • [7] Diastolic Dysfunction in Coronary Artery Disease
    Hashmi, Satwat
    Ahmad, H. R.
    Sharif, Hasanat
    Bokhari, Syedah Saira
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2017, 27 (03): : 192 - 192
  • [8] Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease
    Nilsson, Lennart
    Jonasson, Lena
    Nijm, Johnny
    Hamsten, Anders
    Eriksson, Per
    [J]. CLINICAL CHEMISTRY, 2006, 52 (08) : 1522 - 1527
  • [9] Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease
    Mahmoodi, Khalil
    Kamali, Koorosh
    Karami, Elham
    Soltanpour, Mohammad Soleiman
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2017, 22
  • [10] Evolving focus on diastolic dysfunction in patients with coronary artery disease
    Ohara, Takahiro
    Little, William C.
    [J]. CURRENT OPINION IN CARDIOLOGY, 2010, 25 (06) : 613 - 621
12345